Panbela Therapeutics, Inc. (PBLA) Financials
PBLA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 10.6 million | 13.1 million |
| 2023-06-30 | 19.6 million | 14.7 million |
| 2023-03-31 | 16.5 million | 13.9 million |
| 2022-12-31 | 5.0 million | 13.0 million |
PBLA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -6.7 million | 190000 |
| 2023-06-30 | -5.7 million | 329000 |
| 2023-03-31 | -9.8 million | 180000 |
| 2022-12-31 | -5.0 million | 231000 |
PBLA Net Income
No data available :(
PBLA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 907000 | - | - |
| 2023-06-30 | 7.2 million | - | - |
| 2023-03-31 | 5.2 million | - | - |
| 2022-12-31 | 1.3 million | - | - |
PBLA Shares Outstanding
PBLA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 6.7 million | 1.1 million | - |
| 2023-06-30 | - | 4.2 million | 1.6 million | - |
| 2023-03-31 | - | 3.5 million | 1.4 million | - |
| 2022-12-31 | 1000 | 3.5 million | 1.7 million | - |
PBLA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 7.8 million |
| 2023-06-30 | - | 5.9 million |
| 2023-03-31 | - | 4.9 million |
| 2022-12-31 | -1.6 million | 1.6 million |
PBLA
Price: $0.41
52 week price:
Earnings Per Share: -316.52 USD
P/E Ratio: -0.01
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 2.4 million
Market Capitalization: 2.5 million